CORI DYSON: Open Payments
NPI 1730304874 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,637 in 6 payments from 4 companies in 2025. Trend: 2023 $176 · 2024 $257 · 2025 $1,637
Debt forgiveness: $1,530Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $1,530 |
| Alkermes, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, ARISTADA, INGREZZA, REXULTI.
Industry payments across AR — which companies pay providers there.
